INTRODUCTION
Freshly ejaculated spermatozoa of most mammalian species are unable to fertilize an egg. They acquire this biological activity only after several hours of residence in the female genital tract, a poorly understood process called capacitation (reviewed in refs. [1, 2] . Heparin-like glycosaminoglycans, secreted into the lumen of the female reproductive tract, are present in particularly high concentration in oviductal and uterine fluids during the oestrous cycle, and appear to play a role in fertilization, accelerating the onset of sperm capacitation/acrosome reaction in several mammalian species, such as human [3] , bovine [4] , rabbit [5] and, to some extent, horse [6] . In the bull, these glycosaminoglycans interact with the spermatozoa surface via heparin-binding proteins of seminal plasma origin which coat the spermatozoa on ejaculation and enhance their fertilizing capability [7, 8] . Whether the same holds for other mammalian species remains obscure.
The major heparin-binding proteins from bull seminal plasma [BSP-Al/A2 (also called MP or PDC-109) BSP-A3 and BSP-30K] have been extensively characterized (reviewed in ref. [9] ). However, the molecular mechanism of heparin-binding activity in sperm physiology remains controversial and largely to be determined. Thus Aumiiller et al. [10] have reported that MP (PDC-109) binds to a 65-67 kDa protein(s) on the midpiece of spermatozoa and appears to initiate hyperactive sperm motility. On the other hand, Desnoyers and Manjunath [11] have shown that BSP-A1 (PDC-109) binds specifically to phospholipids containing the phosphorylcholine group, and proposed that this interaction may play an important role in the membrane modification that occurs during capacitation.
Recently, Leblond et al. [12] showed that proteins from the seminal fluids of human, boar, hamster, mouse and rat share fractions. Structural analysis showed that the two HSP-l forms contain identical polypeptide chains which are differently glycosylated. Moreover, size-exclusion chromatography showed that heparin-bound HSP-1 associates with HSP-2, another major seminal plasma protein, into a 90 kDa product, whereas the nonheparin-bound glycoform of HSP-1 is eluted as a monomeric (14 kDa) protein. This suggests that glycosylation may have an indirect effect on the heparin-binding ability of HSP-1 through modulation of its aggregation state. On the other hand, both glycoforms of HSP-1 displayed gelatin-binding activity, indicating that the molecular determinants for binding heparin and gelatin are different.
antigenic determinants with the major heparin-bound proteins of bovine seminal plasma. In the present report we describe the primary structure of HSP-1, a major protein isolated from stallion seminal plasma. HSP-1 is a 121-residue mosaic glycoprotein. Although it shows extensive similarity to the bull BSP proteins and shares with bovine BSP-A1/2 and BSP-A3 the consensus pattern of the gelatin-binding fibronectin type-II modules, it contains an N-terminal extension unrelated to any other known protein structure. In addition, the effect of glycosylation on the aggregation state and the binding activities of HSP-1 is reported.
EXPERIMENTAL Preparation of biological samples
Stallion ejaculates were collected from healthy reproductively active animals by means of an artificial vagina. Spermatozoa were separated from seminal plasma by centrifugation at 1500 g for 15 min at room temperature. The supernatant was further clarified by centrifugation at 12000 g for 10 min. Sperm was washed three times with 20 mM phosphate/1 50 mM NaCl, pH 7.4, by centrifugation as above and the pellet was extracted with acetic acid/glycerol [13] .
Isolation of heparin-bound proteins
Heparin-binding proteins in either seminal plasma or sperm acidic extracts were isolated by affinity chromatography using a heparin-Sepharose CL-6B column (Pharmacia) [14] . Briefly, 10 ml of seminal plasma was applied to a 4 ml heparin-Sepharose ¶ To whom correspondence should be addressed.
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column, washed at a flow rate of 6 ml/h with 20 mM phosphate/150 mM NaCl, pH 7.3, until the absorbance at 280 nm reached baseline. The bound proteins were eluted with an NaCl gradient (0.15-3 M) in the same buffer, at a flow rate of 6 ml/h with an increase in NaCl concentration of 0.0 15 M/min. The fractions were dialysed against water and lyophilized (for structural studies) or dialysed against 50 mM Tris/HCl/ 150 mM NaCl/l mM PMSF/0.025 % NaN3, pH 7.4 (for size-exclusion chromatography). Further purification of proteins was achieved by reverse-phase HPLC on a Lichrospher RP-100 C18 column (25 mm x 4 mm; 5 ,tm particle size; Merck) eluted at 1 ml/min using 0. 1% trifluoroacetic acid in water (solvent A) and acetonitrile (solvent B) first isocratically with 25 % solvent B for 5 min, followed by a gradient of 25-30 % solvent B for 5 min, and 30-70 % solvent B for 160 min.
Affinity chromatography on gelatin-agarose Gelatin-binding proteins present in either whole seminal plasma or the flow-through and heparin-binding fractions were isolated by affinity chromatography on a 10 ml gelatin-agarose column (Sigma). The column and samples were equilibrated with 20 mM phosphate/I mM PMSF/0.025 % NaN3, pH 7.4. After the nonbound proteins had been eluted, bound material was recovered by eluting with the same buffer containing 4 M urea. Both fractions were dialysed against water, lyophilized and their protein composition analysed by reverse-phase HPLC using the same chromatographic conditions as above.
Size-exclusion chromatography Size-exclusion chromatographic analyses of either non-heparinbound and heparin-bound fractions of stallion seminal plasma or mixtures of reverse-phase-isolated proteins of both fractions were carried out using an FPLC system (Pharmacia) with a Superose 12 column equilibrated with 50 mM Tris/HCl/ 150 mM NaCl/ 1 mM PMSF/0.025 % NaN3, pH 7.4, and eluted at 0.3 ml/min. The samples, as obtained from the heparinSepharose column, were dialysed against the size-exclusion column equilibration buffer. A mixture of human IgG (150 kDa), BSA (67 kDa), ovalbumin (43 kDa) and lysozyme (14 kDa) was used as a standard for molecular-size calibration of the column.
Proteolytic degradation of HSP-1
For enzymic digestion of HSP-1, the isolated protein (2-5 mg/ml in 100 mM Tris/HCI/1 M guanidinium chloride, pH 8.6) was reduced and pyridylethylated [15] , dialysed against the same buffer, and incubated with either Tos-Phe-CH2Cl ('TPCK')-treated trypsin (Sigma) or endoproteinase Asp-N (BoehringerMannheim) at an enzyme/substrate ratio of 1:100 (w/w) for 18 h at 37 'C. Peptides were isolated by reverse-phase HPLC as above with isocratic elution at 10 % solvent B for 5 min followed by a gradient of 5-50 % solvent B in 90 min.
Quantification of thlol groups and disulphide bonds Titration of free cysteine residues and disulphide bridges was carried out as described previously [16] . For localization of cystine residues, native non-heparin-binding HSP-1 was degraded with trypsin and heparin-binding HSP-l was digested with chymotrypsin (Sigma), using the same conditions as for tryptic digestion, and the peptides were isolated by reverse-phase HPLC Analytical methods SDS/PAGE was carried out as described by Laemmli [17] .
N-terminal amino acid sequencing was performed using a model 473A gas-liquid phase sequencer (Applied Biosystems) following the manufacturer's instructions. Amino acid similarity searches were carried out using the program FASTA [18] from the GCG Sequence Analysis Software Package (version 7.0, April 1991) and the protein sequences deposited in the data bank of the Martinsried Institute for Protein Sequences (MIPS).
HSP-1 was chemically deglycosylated using HF [19] with an incubation time of 1 h at 23 'C.
Amino acid analyses were carried out using an Alpha Plus (Pharmacia) amino acid analyser after sample hydrolysis at 110 'C with 6 M HCI for 24 h. For amino sugar and neutral sugar analyses, the samples were hydrolysed at 110°C with 4 M HCl for 4 h or 2 M HCl for 2 h respectively. Sialic acid was determined after hydrolysis at 80 'C with 0.2 M trifluoroacetic acid. Monosaccharides were resolved on a CarboPac PAl column (4 mm x 250 mm) eluted isocratically at 1 ml/min with either 16 mM NaOH (amino and neutral sugars) or 20 mM NaOH in 60 mM sodium acetate, and analysed using a Dionex DX-300 carbohydrate analyser equipped with a pulsed amperometric detector and the AI-450 chromatographic software [20] .
Fast-atom-bombardment mass spectra of peptides were recorded with a mass spectrometer MAT 900 (Finnigan MAT, Bremen, Germany) equipped with a liquid secondary-ion ionization system. The molecular masses of proteins were determined by matrix-assisted laser desorption ionization time-offlight MS using a fOCUS LD-TOF (GSG, Karlsruhe) mass spectrometer and a-cyano-4-hydroxycinnamic acid as a matrix.
Lectin mapping
The structure of oligosaccharides was studied by lectin mapping [21] Samples containing 1 jug of HSP-l and HSP-2 (in 100,1 of 50 mM NaHCO3, pH 9.6), isolated from either the heparinbinding or non-heparin-binding fractions of stallion seminal plasma, were coated overnight at 4 'C on to wells of a microtitre plate. Thereafter, the samples were incubated with 200 1dl of 20 mM Tris/HCl/150 mM NaCl/5 % BSA/0.1 % Triton X-100, pH 7.4 (blocking buffer) for 1 h at 37 'C, followed by different amounts of biotinylated lectins (5-100 ,u,g/ml in the same buffer) for 1 h at 37 'C. The plate was then washed with blocking buffer, incubated with 1001ul of a 1:4000 dilution of streptavidinperoxidase conjugate (Sigma) for 1 h at 37 'C, washed with blocking buffer, and finally developed with 100 ,ul/well 2 mg/ml o-phenylenediamine in 20 mM citric acid, 50 mM NaH2PO4 buffer pH 5, containing 70 #1 of H202 (30 %/100 ml). The colour developed was measured at 492 nm with an automated micro-ELISA reader (ICN).
RESULTS
Isolation and characterization of stallion seminal plasma proteins Stallion seminal plasma was fractionated by affinity chromatography on a heparin-Sepharose column, and the as above, and characterized by amino acid analysis. proteins of the unbound and bound fractions were isolated by reverse-phase HPLC (Figure 1 ). The heparin-bound fraction contained three major components with apparent molecular masses on SDS/PAGE of 30, 25 and 16 kDa (Figure la, inset) . Whereas the 16 kDa protein was quantitatively retained in the affinity matrix, the 30 and 25 kDa proteins were also found in the non-heparin-bound fraction (Figure lb) . This was not due to saturation of the affinity matrix, as the unbound proteins did not bind to the heparin-Sepharose column on rechromatography.
N-Terminal sequence analysis of the reduced and carboxymethylated heparin-bound proteins of 30 and 25 kDa apparent molecular masses (henceforth called HSP-1 and HSP-2 respectively) showed that they belong to the same protein family, although the former contains a 15 amino acid-long N-terminal extension: HSP-1 chemically deglycosylated with HF showed that the four unidentified residues were threonines. The N-terminal sequence of HSP-2 showed two residues at positions 2, 9, 13, 17, 20, 24 and 26, indicating that the HSP-2 fraction may contain two or more highly related polypeptides.
The same N-terminal amino acid sequences were obtained when the non-heparin-binding HSP-1 and HSP-2 proteins were analysed. In addition, compositional analyses (Table 1) showed that, whereas the heparin-bound and non-heparin-bound forms of HSP-2 were indistinguishable, the heparin-bound and nonheparin-bound HSP-1 proteins contained the same amino acid composition but differed in their carbohydrate content. These results were confirmed by lectin mapping (Figure 2 ): both glycoforms of HSP-1 reacted with lectin ACA, but only HSP-1 of the heparin-binding fraction bound lectin MAA. On the other hand, HSP-2 isolated from either of the heparin-affinitychromatography fractions were positive for lectins ACA and MAA. None of the proteins reacted with lectins SNA and DSA.
Altogether, compositional and lectin-mapping analyses suggested that heparin-bound HSP-1 contains four 0-glycosylation sites at positions 5, 12, 22 and 27 occupied, most probably, by NeuNAc(a2-3)Gal(/l-3)GalNAc oligosaccharides, whereas non-heparin-bound HSP-1 may contain a disaccharide Gal(/51-3)GaINAc and three GalNAc residues. HSP-2 in both fractions may have two glycosylation sites at positions 7 and 12 each occupied with a structure most probably identical with those of heparin-bound HSP-1.
Analysis of HSP-1 isolated from the heparin-bound fraction by plasma desorption time-of-flight MS showed a broad peak with a centroid at 16 kDa, and MS analysis of non-heparinbound HSP-1 showed a heterogeneous peak between 14.9 and 15.2 kDa. On the other hand, HSP-2 isolated from the heparin- bound and non-heparin-bound fractions yielded in both cases heterogeneous broad peaks of molecular ions in the range of 14.0-14.7 kDa. These values are in contrast with the molecular masses determined by SDS/PAGE. The known altered electrophoretic mobility ofglycoproteins may account for the difference. The N-terminal amino acid sequence of the 16 kDa protein was AWNRRSRSXGGVLR. We have previously shown that the 16 kDa protein cross-reacted with polyclonal monospecific antibodies against porcine spermadhesin AWN [22] . Here we show that the N-terminal amino acid sequence of the stallion 16 kDa protein is identical with porcine AWN [23] , indicating that these proteins are immunologically and structurally related.
HSP-1 and HSP-2 proteins as well as the 16 kDa AWN-like protein were present in acidic extracts of ejaculated spermatozoa (Figure 1 ), indicating that they have the ability to bind to the sperm surface.
Binding of HSP-1 and HSP-2 to gelatin-agarose When stallion seminal plasma was chromatographed on a gelatin-agarose column, all HSP-1 and HSP-2 glycoforms, but not the 16 kDa AWN-like protein, were quantitatively bound to the affinity matrix. The same result was obtained when the nonheparin-bound and heparin-bound fractions of seminal plasma were fractionated by gelatin-agarose chromatography. Furthermore, reverse-phase-isolated HSP-1 and HSP-2 proteins, from either the heparin-bound or non-heparin-bound fractions of seminal plasma, also possessed the capability to bind gelatin.
Size-exclusion chromatography of HSP-1 and HSP-2 proteins
When the proteins of the non-heparin-bound and heparin-bound fractions were separated using size-exclusion chromatography (Figure 3) , it was found that non-heparin-bound HSP-1 and HSP-2 proteins were eluted as monomeric proteins, i.e. at a position where the molecular mass standard of 14 kDa is eluted.
On the other hand, heparin-bound HSP-l and HSP-2 were both recovered as aggregated molecules with an apparent molecular mass of 90 kDa (Figure 3 ). HSP-1 and HSP-2 accounted for more than 90 % of the total proteins of the 90 kDa eluate, as judged by reverse-phase chromatography (Figure 3b) . Quantification of HSP-1 and HSP-2 in the 90 kDa eluate indicated that the two proteins were present in equimolar amounts. The other major heparin-binding protein, the 16 kDa AWN-related protein (Figure la, peak 3) , was eluted as a monomer.
To test the possibility that the aggregation state of HSP-1 and HSP-2 molecules determined their ability to bind heparin, HSP-1 and HSP-2 glycoforms in the 90 kDa heparin-bound aggregate were separated by reverse-phase HPLC (as in Figure 1 ) and the ability of the isolated proteins to bind to a heparin-Superose column was investigated. It was found that neither HSP-1 nor HSP-2 displayed heparin-binding activity. Analysis by sizeexclusion chromatography of reverse-phase-isolated HSP-1 and HSP-2 molecules showed that their apparent molecular size, which was in both cases 14 kDa, was indistinguishable from that of the HSP-1 and HSP-2 glycoforms of the non-heparin-bound fraction of intact seminal plasma. To investigate whether reverse-phase-isolated HSP proteins could reassociate into a heparin-binding complex, equimolar mixtures of HSP-1 and HSP-2, purified from the heparin-bound (Hep+) or non-heparin-bound (Hep-) fraction of seminal plasma, were analysed by size-exclusion chromatography followed by heparin-Sepharose chromatography and reverse-phase HPLC. When HSP-1 /Hep-was mixed with HSP-2/Hep+ or HSP-2/Hep-, the proteins were coeluted with an apparent molecular mass of 14 kDa and did not bind to heparin-Sepharose. However, when the same experiment was carried out using HSP-1/Hep+, around 20 % of molecules formed a 90 kDa heparin-binding 1: 1 heterodimer with HSP-2 (whether Hep+ or Hep-) (not shown).
The remaining proteins (80%) were recovered as monomeric (14 kDa) molecules, probably because they were irreversibly denatured under reverse-phase chromatographic conditions, and were unable to bind to the heparin-Sepharose column. Table 2 shows the structure of the four disulphide-bridged peptides of HSP-1.
The primary structure of HSP-1
Sequence analyses of reduced and pyridylethylated heparinbound HSP-1 and HPLC-isolated peptides obtained by proteolytic digestion of pyridylethylated HSP-1 with endoproteinase Asp-N, chymotrypsin and Tos-Phe-CH2Cl-trypsin (chromatograms not shown) provided the necessary overlapping peptides to derive the amino acid sequence of the protein (Figure 4 ).
The 121-residue-long sequence accounts for the complete amino acid sequence of HSP-1 because (a) all the isolated peptides are assigned within this structure and (b) peptides T12, D4, D9 and C1 (Figure 4) , derived by proteolysis of HSP-1 with enzymes with different cleavage specificity, all contain the same C-terminal sequence. In addition, compositional analysis of HSP-1 (Table 1) showed that its amino acid composition fits almost exactly with that expected from the amino acid sequence. Furthermore, peptides DI and D3 each contained 1 mol of sialic acid, galactose and galactosamine/mol of peptide, and D6 contained 2.8:3.1:2.6 mol of sialic acid, galactose and galactosamine/mol of peptide respectively, confirming that HSP- 1 is a glycoprotein containing four 0-glycosylation sites. Finally, the average molecular mass calculated for the amino acid sequence of HSP-1 with four carbohydrate chains with the structure NAcNeu-Gal-GalNAc, and taking into account that HSP-1 contains four disulphide bridges, is 16604.6 Da, which is in excellent agreement with the measured molecular mass of HSP-1 isolated from the heparin-bound fraction of seminal plasma. Analysis of tryptic peptides derived from the non-heparinbound glycoform of HSP-1 (labelled T*-in Figure 4) showed that its amino acid sequence is identical with that of heparinbinding HSP-1. This, together with compositional-analysis (Table 1) and lectin-mapping results (Figure 2) , further indicates that the non-heparin-bound and heparin-bound HSP-1 proteins are glycoforms, and that the carbohydrate content of nonheparin-bound HSP-1 is lower than that of the heparin-bound glycoforms.
Disulphide bridge pattern of HSP-1 When native HSP-1 (either heparin-bound or non-heparin-bound glycoform) was treated with iodoacetamide under denaturing but non-reducing conditions, no thiol groups were detected, whereas after reduction and pyridylethylation, 6.2-6.4 mol of pyridylethylcysteine residues/100 mol of total amino acids were found in the acid hydrolysate (Table 1 ). This indicates that either glycoform of HSP-1 may contain four intrachain disulphide bridges. The disulphide-bonding pattern was established after chymotryptic and tryptic digestion of the native proteins and analysis of the HPLC-purified peptides (Figure 4 ). Fragments C1, C8, C12 and C1 3 of heparin-bound HSP-1 and peptides T*-12, T*-13, T*-14 and T*-15 of non-heparin-bound HSP-1 ( Figure  4 , Table 2 ) each contained two disulphide-bonded peptides. [24] and BSP-A3 [25] (Figure 6 ), which in turn share the invariant residues and the topology of the disulphide bonds found in the heparin-and gelatin-binding fibronectin type-II module in a large number of mosaic proteins [26] . On the other hand, the sequence of the A'-domain can only be aligned with the bovine proteins by introducing numerous gaps, and the N-terminal A-domain is absent from PDC-109 and BSP-A3 ( Figure 6 ).
DISCUSSION
Analysis of HSP-1 and HSP-2 proteins present in the nonheparin-bound and heparin-bound fractions of stallion seminal plasma showed that the two fractions contained identical HSP-2 molecules but different glycoforms of HSP-1. Furthermore, non-heparin-binding HSP-1 and HSP-2 glycoforms behave as monomeric proteins by size-exclusion chromatography, whereas heparin-binding HSP-1 and HSP-2 glycoproteins were eluted as aggregated molecules with an apparent molecular mass of 90 kDa (Figure 3a) . Neither [24] and BSP-A3 [25] Identical residues in at least two proteins are shown in boxes. The consensus amino acids of the fibronectin type-Il module and the spacing between them [26] are shown below the sequences alignment. Essential residues for gelatin-binding are labelled with + below the sequence.
heparin-bound fraction of seminal plasma). Our interpretation of these data is that glycosylation may have an indirect effect on the heparin-binding activity of HSP-1 and HSP-2 through modulation of the aggregation state of HSP-1. As in the 90 kDa heparin-binding complex HSP-1 and HSP-2 molecules were found in equimolar amounts, our hypothesis is that aggregated HSP-l glycoforms associate with HSP-2 with a 1: 1 stoichiometry, and that a binding surface for heparin is then formed on the oligomer. We are currently investigating the size of this oligomer, for which a stoichiometry (HSP-1)3(HSP-2)3 was calculated from the above size-exclusion data. The amino acid sequence of HSP-l (Figure 4) showed that the protein contains two types of homologous repeats arranged in a modular structure AA'BB' (Figure 5 ). Except for the N-terminal A-type domain, the rest of the structure shows a high degree of similarity to the major bovine heparin-binding seminal plasma proteins PDC-109 and BSP-A3 ( Figure 6 ). Remarkably, the HSP-l 0-glycosylated Thr-22 (also present in HSP-2 at position 7) corresponds to Thr-l 1 of PDC-109, the single 0-glycosylation site of the molecule that is occupied by the trisaccharide NeuNAc(a2-6)Gal(J1l-3)GalNAc [27] . Interestingly, only the HSP-1 glycoforms present in the 90 kDa heparin-binding aggregate contain similar carbohydrate structures. Furthermore, like heparin-binding HSP-1, PDC-109 was eluted, together with BSP-A2 (a non-glycosylated form of PDC-109 [27] ), as aggregated molecules (60-120 kDa) during gel filtration [28] . This is at odds with our hypothesis that oligomerization may be a molecular determinant for expression of the heparin-binding activity on fibronectin type-Il domain-containing seminal plasma proteins, and raises the question of whether the 0-glycosylation site, the position and structure of which are conserved in bovine PDC-109 and stallion HSP-1, is a major determinant for oligomerization.
On the other hand, both non-heparin-bound and heparinbound HSP-1 and HSP-2 glycoproteins bound quantitatively to a gelatin-agarose column, and the gelatin-binding capability was independent of the aggregation state of the seminal plasma proteins. This indicates that different molecular determinants are responsible for expressing the heparin-and gelatin-binding activities. Bovine PDC-109 (BSP-Al) is also a gelatin-binding protein [29] . Indeed, both the B-domains of HSP-1 and PDC-109 contain most of the essential amino acids that define a gelatinbinding site [30] (labelled + in Figure 6 ). The previous observation that a 45-residue single type-II domain of PDC-109 (which corresponds to a single HSP-1 B-domain) retains a collagen (gelatin)-binding site [29] agrees with our conclusion that oligomerization is not required for gelatin binding, and indicates that each HSP-l molecule may carry two such binding sites.
In the bull, heparin-binding proteins become adsorbed to the sperm surface on exposure of epididymal spermatozoa to seminal plasma from the same species and modulate capacitation by heparin [31] . The major heparin-binding proteins of bovine seminal plasma (PDC-109 and BSP-A3) are structurally related to stallion HSP-1 and most probably also to HSP-2 ( Figures 5   and 6 ), and HSP-l and HSP-2 were also found in acidic extracts of ejaculated washed spermatozoa. These data suggest a possible role for the heparin-binding HSP-1-HSP-2 complex in the reported initiation of the capacitation/acrosome reaction of equine sperm modulated by heparin in vitro [6] . To understand the physiological relevance of these seminal plasma proteins requires further detailed investigation.
